Most of the infants are born normal and healthy at the time of birth and with no family history of disorders . Unfortunately, once symptom appears in child, they are often irreversible leading to severe health and developmental problems. Newborn screening helps in identifying diseases, which can affect a child鈥檚 health in the long run, at an early stage. Newborn screening, which includes a series of tests, is essential for early detection, diagnosis, and management , to prevent disability and death of a child. These tests, which are performed shortly after the birth of a baby, are used for the detection of genetic, developmental, and metabolic disorders in newborn babies.
The global New-Born Screening market was valued at US$ 790.6 million in 2023 and is anticipated to reach US$ 1357.7 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
North America dominates the global market for newborn screening due to the need for reducing healthcare cost . Asia is expected to witness high growth rates in the next five years in the newborn screening market . China and India are expected to be the fastest-growing newborn screening markets in Asia Pacific. Some of the key growth drivers of the newborn screening market in emerging countries are the large pool of patients, increasing healthcare expenditure, and rising government funding and initiatives.
This report aims to provide a comprehensive presentation of the global market for New-Born Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New-Born Screening.
Report Scope
The New-Born Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global New-Born Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the New-Born Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
GE Healthcare
Trivitron Healthcare
AB Sciex
Perkinelmer
Bio-Rad Laboratories
Agilent Technologies
Medtronic
Masimo
Waters
Natus Medical
Segment by Type
Tandem Mass Spectrometry
Pulse Oximetry Screening Technology
DNA-Based Assays
Hearing Screen Technology
Others
Segment by Application
Hospitals
Clinics
Nursing 麻豆原创s
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of New-Born Screening companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global New-Born Screening 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tandem Mass Spectrometry
1.2.3 Pulse Oximetry Screening Technology
1.2.4 DNA-Based Assays
1.2.5 Hearing Screen Technology
1.2.6 Others
1.3 麻豆原创 by Application
1.3.1 Global New-Born Screening 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Nursing 麻豆原创s
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global New-Born Screening 麻豆原创 Perspective (2019-2030)
2.2 New-Born Screening Growth Trends by Region
2.2.1 Global New-Born Screening 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 New-Born Screening Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 New-Born Screening Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 New-Born Screening 麻豆原创 Dynamics
2.3.1 New-Born Screening Industry Trends
2.3.2 New-Born Screening 麻豆原创 Drivers
2.3.3 New-Born Screening 麻豆原创 Challenges
2.3.4 New-Born Screening 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top New-Born Screening Players by Revenue
3.1.1 Global Top New-Born Screening Players by Revenue (2019-2024)
3.1.2 Global New-Born Screening Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global New-Born Screening 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by New-Born Screening Revenue
3.4 Global New-Born Screening 麻豆原创 Concentration Ratio
3.4.1 Global New-Born Screening 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by New-Born Screening Revenue in 2023
3.5 New-Born Screening Key Players Head office and Area Served
3.6 Key Players New-Born Screening Product Solution and Service
3.7 Date of Enter into New-Born Screening 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 New-Born Screening Breakdown Data by Type
4.1 Global New-Born Screening Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global New-Born Screening Forecasted 麻豆原创 Size by Type (2025-2030)
5 New-Born Screening Breakdown Data by Application
5.1 Global New-Born Screening Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global New-Born Screening Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America New-Born Screening 麻豆原创 Size (2019-2030)
6.2 North America New-Born Screening 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America New-Born Screening 麻豆原创 Size by Country (2019-2024)
6.4 North America New-Born Screening 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe New-Born Screening 麻豆原创 Size (2019-2030)
7.2 Europe New-Born Screening 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe New-Born Screening 麻豆原创 Size by Country (2019-2024)
7.4 Europe New-Born Screening 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific New-Born Screening 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific New-Born Screening 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific New-Born Screening 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific New-Born Screening 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America New-Born Screening 麻豆原创 Size (2019-2030)
9.2 Latin America New-Born Screening 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America New-Born Screening 麻豆原创 Size by Country (2019-2024)
9.4 Latin America New-Born Screening 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa New-Born Screening 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa New-Born Screening 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa New-Born Screening 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa New-Born Screening 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare New-Born Screening Introduction
11.1.4 GE Healthcare Revenue in New-Born Screening Business (2019-2024)
11.1.5 GE Healthcare Recent Development
11.2 Trivitron Healthcare
11.2.1 Trivitron Healthcare Company Detail
11.2.2 Trivitron Healthcare Business Overview
11.2.3 Trivitron Healthcare New-Born Screening Introduction
11.2.4 Trivitron Healthcare Revenue in New-Born Screening Business (2019-2024)
11.2.5 Trivitron Healthcare Recent Development
11.3 AB Sciex
11.3.1 AB Sciex Company Detail
11.3.2 AB Sciex Business Overview
11.3.3 AB Sciex New-Born Screening Introduction
11.3.4 AB Sciex Revenue in New-Born Screening Business (2019-2024)
11.3.5 AB Sciex Recent Development
11.4 Perkinelmer
11.4.1 Perkinelmer Company Detail
11.4.2 Perkinelmer Business Overview
11.4.3 Perkinelmer New-Born Screening Introduction
11.4.4 Perkinelmer Revenue in New-Born Screening Business (2019-2024)
11.4.5 Perkinelmer Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories New-Born Screening Introduction
11.5.4 Bio-Rad Laboratories Revenue in New-Born Screening Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Detail
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies New-Born Screening Introduction
11.6.4 Agilent Technologies Revenue in New-Born Screening Business (2019-2024)
11.6.5 Agilent Technologies Recent Development
11.7 Medtronic
11.7.1 Medtronic Company Detail
11.7.2 Medtronic Business Overview
11.7.3 Medtronic New-Born Screening Introduction
11.7.4 Medtronic Revenue in New-Born Screening Business (2019-2024)
11.7.5 Medtronic Recent Development
11.8 Masimo
11.8.1 Masimo Company Detail
11.8.2 Masimo Business Overview
11.8.3 Masimo New-Born Screening Introduction
11.8.4 Masimo Revenue in New-Born Screening Business (2019-2024)
11.8.5 Masimo Recent Development
11.9 Waters
11.9.1 Waters Company Detail
11.9.2 Waters Business Overview
11.9.3 Waters New-Born Screening Introduction
11.9.4 Waters Revenue in New-Born Screening Business (2019-2024)
11.9.5 Waters Recent Development
11.10 Natus Medical
11.10.1 Natus Medical Company Detail
11.10.2 Natus Medical Business Overview
11.10.3 Natus Medical New-Born Screening Introduction
11.10.4 Natus Medical Revenue in New-Born Screening Business (2019-2024)
11.10.5 Natus Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
GE Healthcare
Trivitron Healthcare
AB Sciex
Perkinelmer
Bio-Rad Laboratories
Agilent Technologies
Medtronic
Masimo
Waters
Natus Medical
听
听
*If Applicable.
